Your browser doesn't support javascript.
loading
An Updated Systematic Review on Remdesivir's Safety and Efficacy in Patients Afflicted With COVID-19.
Yasir, Mohamed; Lankala, Chetan Reddy; Kalyankar, Pravin; Ishak, Angela; Mekhail, Mario; Sestacovschi, Cristina; Kima, Elias.
Afiliación
  • Yasir M; Division of Research, California Institute of Behavioral Neurosciences and Psychology, Fairfield, USA.
  • Lankala CR; Department of Internal Medicine, Uzhhorod National University, Uzhhorod, UKR.
  • Kalyankar P; Department of Internal Medicine, Fortis Escorts Hospital, Faridabad, IND.
  • Ishak A; Division of Research and Academic Affairs, Larkin Community Hospital, Miami, USA.
  • Mekhail M; Department of Internal Medicine, New York University (NYU) Langone Long Island Community Hospital, New York, USA.
  • Sestacovschi C; Division of Research and Academic Affairs, Larkin Community Hospital, Miami, USA.
  • Kima E; Division of Research and Academic Affairs, Larkin Community Hospital, Miami, USA.
Cureus ; 15(8): e43060, 2023 Aug.
Article en En | MEDLINE | ID: mdl-37680394
Globally, the coronavirus disease 2019 (COVID-19) had a significant impact on everyone's lives and put a tremendous strain on healthcare systems. Since the outbreak began, remdesivir has been investigated as a potential treatment for COVID-19 that may be both effective and safe. Remdesivir has had a huge impact on the disease's progression, complications, and mortality. This review provides an updated assessment of the literature regarding remdesivir's efficacy and safety for the treatment of patients with COVID-19. The search was performed through PubMed, Web of Science, Cochrane, and Scopus for articles published from 2019 to September 20, 2022. Studies that assessed remdesivir's efficacy and safety were included in this review, with clinical improvements as the primary outcome measure. Seventeen studies were identified following the implementation of the search strategy. Among them, 11 corroborated remdesivir's efficacy. Meanwhile, the remaining six studies did not observe a statistically significant difference in clinical improvement. Remdesivir is a potentially safe and effective antiviral that shows clinical improvement especially when used during the early course of the disease. However, current literature still questions its safety in patients who are afflicted with the complications of COVID-19, highlighting the need for studies on a large scale.
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Systematic_reviews Idioma: En Revista: Cureus Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Systematic_reviews Idioma: En Revista: Cureus Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos